ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups

Quinn, DI; Ng, CF; Grande, E; Kwon, TG; Linke, R; Lee, JL; Rosbrook, B; Thakur, MN; Eto, M; Gross-Goupil, M

Quinn, DI (corresponding author), USC, Keck Sch Med, Norris Comprehens Canc Ctr, 1441 Eastlake Ave,Suite 3440, Los Angeles, CA 90033 USA.

ESMO OPEN, 2021; 6 (3):

Abstract

Background: The ATLAS trial, investigating adjuvant axitinib versus placebo in renal cell carcinoma (RCC), was stopped for futility at a preplanned in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索